Systematic review of surgical management of synchronous colorectal liver metastases, British Journal of Surgery, vol.15, issue.6, pp.605-617, 2014. ,
DOI : 10.1111/j.1477-2574.2012.00597.x
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?, Journal of Clinical Oncology, vol.27, issue.11, pp.1829-1864, 2009. ,
DOI : 10.1200/JCO.2008.19.9273
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.25, issue.suppl 3, pp.1-9, 2014. ,
DOI : 10.1093/annonc/mdu260
The Natural History of Hepatic Metastases from Colorectal Cancer, Annals of Surgery, vol.199, issue.5, pp.502-510, 1984. ,
DOI : 10.1097/00000658-198405000-00002
Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.262, issue.3, pp.476-85, 2015. ,
DOI : 10.1097/SLA.0000000000001427
Management of colorectal cancer presenting with synchronous liver metastases, Nature Reviews Clinical Oncology, vol.52, issue.8, pp.446-59, 2014. ,
DOI : 10.1634/theoncologist.2012-0121
Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases, Annals of Surgical Oncology, vol.243, issue.29, pp.242-290, 2016. ,
DOI : 10.1097/01.sla.0000193603.26265.c3
Cancer Concepts and Principles: Primer for the Interventional Oncologist???Part II, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1167-88, 2013. ,
DOI : 10.1016/j.jvir.2013.04.023
Bevacizumab plus FOLFOX or FOLFIRI Regimens on Patients with Unresectable Liver-Only Metastases of Metastatic Colorectal Cancer, Advanced Biomedical Research, vol.5, 2016. ,
Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective, Liver Cancer, vol.4, issue.4, pp.208-1410, 2015. ,
DOI : 10.1159/000367747
Y90 Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 2015. ,
Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 Patients, Annals of Surgical Oncology, vol.2011, issue.3 ,
DOI : 10.1371/journal.pone.0069448
Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy, Journal of Vascular and Interventional Radiology, vol.23, issue.3, pp.287-94, 2012. ,
DOI : 10.1016/j.jvir.2011.11.029
Intra-Arterial Infusion of Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) versus Intravenous Therapy (FOLFIRI) for Hepatic Metastases from Colorectal Cancer: Final Results of a Phase III Study, Anticancer Research, vol.32, issue.4, pp.1387-95, 2012. ,
Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry, CardioVascular and Interventional Radiology, vol.84, issue.5, pp.960-66, 2010. ,
DOI : 10.1155/2009/539795
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-Eluting Beads: Results of a Phase II Clinical Study, In Vivo, vol.21, issue.6, pp.1085-91, 2007. ,
Chemoembolization in Colorectal Liver Metastases: The Rebirth, Anticancer Research, vol.34, issue.2, pp.575-84, 2014. ,
Pharmacologic rationale for regional drug delivery., Journal of Clinical Oncology, vol.2, issue.5, pp.498-504, 1984. ,
DOI : 10.1200/JCO.1984.2.5.498
Transarterial Chemoembolization with Irinotecan Beads in the Treatment of Colorectal Liver Metastases: Systematic Review, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1209-1226, 2013. ,
DOI : 10.1016/j.jvir.2013.05.055
Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer, Journal of Vascular and Interventional Radiology, vol.24, issue.4, pp.2077-83, 2013. ,
DOI : 10.1016/j.jvir.2013.01.030
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI), International Journal of Oncology, vol.41, issue.4, pp.1213-1233, 2012. ,
DOI : 10.3892/ijo.2012.1572
Real- Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer, Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer, Gastroenterology Research and Practice, vol.10, pp.715102-715112, 1155. ,
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis, Cancer, vol.25, issue.suppl 4, pp.3649-58, 2015. ,
DOI : 10.1016/j.jvir.2013.11.027
Transarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations, Journal of Vascular and Interventional Radiology, vol.25, issue.3, pp.365-69, 2014. ,
DOI : 10.1016/j.jvir.2013.11.027
Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true?, Annals of Oncology, vol.10, issue.6, pp.623-629, 1999. ,
DOI : 10.1023/A:1008353227103
Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer, Oncology, vol.15, issue.3, pp.222-252, 2006. ,
DOI : 10.1016/S0140-6736(00)02034-1
Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial, Journal of Clinical Oncology, vol.24, issue.31, pp.4976-82, 2006. ,
DOI : 10.1200/JCO.2006.06.8353
URL : https://hal.archives-ouvertes.fr/hal-00485672
Review of Systemic Therapies for Locally Advanced and Metastatic Rectal Cancer, Journal of Gastrointestinal Oncology, vol.6, issue.2, 2015. ,
Section III: Treatment of Advanced Gastrointestinal Cancers, Gastrointestinal Cancer Research, vol.1, issue.6 ,
Current treatment for colorectal liver metastases, World Journal of Gastroenterology, vol.17, issue.36, pp.4067-75, 2011. ,
DOI : 10.3748/wjg.v17.i36.4067
Cancer Statistics, 2007, CA: A Cancer Journal for Clinicians, vol.57, issue.1, pp.43-66, 2007. ,
DOI : 10.3322/canjclin.57.1.43
Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data, Journal of Clinical Oncology, vol.28, issue.2, pp.264-71, 2010. ,
DOI : 10.1200/JCO.2009.24.0952
TNM Classification of Malignant Tumours, 2009. ,
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1023, 2008. ,
DOI : 10.1016/S0140-6736(08)60455-9
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-221, 2000. ,
DOI : 10.1093/jnci/92.3.205
Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data, Journal of Clinical Oncology, vol.28, issue.2, pp.264-71, 2010. ,
DOI : 10.1200/JCO.2009.24.0952
org -Société Savante Médicale Française D'hépato-Gastroentérologie et D'oncologie Digestive, 2016. ,
Targeting Colorectal Cancer with Human Anti-EGFR Monoclonocal Antibodies: Focus on Panitumumab, Biologics : Targets & Therapy, vol.2, issue.2, pp.223-251, 2008. ,
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.25, issue.13, pp.1658-64, 2007. ,
DOI : 10.1200/JCO.2006.08.1620
Comparative Efficacy of Adjuvant Chemotherapy in Patients with Dukes' B versus Dukes' C Colon Cancer: Results from Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04), Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.17, issue.5, pp.1349-55, 1999. ,
Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum, and Meta-Analysis Group in Cancer Efficacy of Oral Adjuvant Therapy after Resection of Colorectal Cancer: 5-Year Results from Three Randomized Trials, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.22, issue.3, pp.484-92, 2004. ,
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies, Indian Journal of Medical and Paediatric Oncology, vol.35, issue.3, pp.197-202, 2014. ,
DOI : 10.4103/0971-5851.142032
Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care???s Gastrointestinal Cancer Disease Site Group, Journal of Clinical Oncology, vol.22, issue.16, pp.3395-3407, 2004. ,
DOI : 10.1200/JCO.2004.03.087
Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features, Journal of Clinical Oncology, vol.29, issue.25, pp.3381-88, 2011. ,
DOI : 10.1200/JCO.2010.34.3426
Counting alleles to predict recurrence of early-stage colorectal cancers, The Lancet, vol.359, issue.9302, pp.219-244, 2002. ,
DOI : 10.1016/S0140-6736(02)07448-2
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-51106147, 1200. ,
DOI : 10.1200/JCO.2008.19.6147
Should DUKES'B patients recieve adjuvant therapy ? A statistical perspective, Sem Oncol, vol.1, issue.1, pp.20-24, 2001. ,
GIVIO-SITAC 01, Cancer, vol.15, issue.11, pp.2135-2179, 1998. ,
DOI : 10.1093/jnci/88.15.1039
Oral Uracil and Tegafur Plus Leucovorin Compared With Intravenous Fluorouracil and Leucovorin in Stage II and III Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-06, Journal of Clinical Oncology, vol.24, issue.13, pp.2059-64, 2006. ,
DOI : 10.1200/JCO.2005.04.7498
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer, Gastroenterology, vol.106, issue.4, pp.899-906, 1994. ,
DOI : 10.1016/0016-5085(94)90748-X
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer., Journal of Clinical Oncology, vol.15, issue.1, pp.246-50, 1997. ,
DOI : 10.1200/JCO.1997.15.1.246
Adjuvant Chemotherapy versus Observation in Patients with Colorectal Cancer: A Randomised Study, The Lancet, vol.370, issue.1507, pp.2020-2049, 2007. ,
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089, Journal of Clinical Oncology, vol.23, issue.34, pp.8671-78, 2005. ,
DOI : 10.1200/JCO.2004.00.5686
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma, New England Journal of Medicine, vol.322, issue.6, pp.352-360, 1990. ,
DOI : 10.1056/NEJM199002083220602
Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial, Journal of Clinical Oncology, vol.21, issue.15, pp.2896-903, 2003. ,
DOI : 10.1200/JCO.2003.10.065
Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients (abstr 3576), J Clin Oncol, vol.23, p.251, 2005. ,
Folinic acid modulated bolus 5-FU or infusional 5- FU for adjuvant treatment of patients of UICC stage III colon cancer: Preliminary analysis of the PETACC-2-study, J Clin Oncol, vol.24, issue.18S, p.3563, 2006. ,
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer, New England Journal of Medicine, vol.352, issue.26, pp.2696-2704, 2005. ,
DOI : 10.1056/NEJMoa043116
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy, Annals of Oncology, vol.23, issue.5, pp.366-376, 2011. ,
DOI : 10.1093/annonc/mdr366
A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases, European Radiology, vol.25, issue.12, pp.10-1007, 2016. ,
DOI : 10.1007/s00330-015-3615-5
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases, Cancer, vol.233, issue.12, pp.2658-70, 2005. ,
DOI : 10.1097/00000658-200103000-00001
Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis???Meta-analysis, Radiology, vol.237, issue.1, pp.123-154, 2005. ,
DOI : 10.1148/radiol.2371042060
Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized Study, Journal of Nuclear Medicine, vol.50, issue.7, 2009. ,
DOI : 10.2967/jnumed.109.063040
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bévacizumab as firts-lin treatment of metastatic colorectl cancer : results of the TREE Study, Journal of Clinical Oncology, 2008. ,
Intraperitoneal chemohyperthermia and attemped cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origine, Brittish Journal of Surgery, vol.91, pp.747-54, 2004. ,
Quelle est la place de la chimiothérapie néoadjuvante, adjuvante et palliative dans la prise en charge des métastases hépatiques d'ogigine colorectale ?, Gastroenterol Clin Biol, vol.27, issue.suppl2, pp.63-79, 2003. ,
Survival after Liver Resection in Metastatic Colorectal Cancer: Review and Meta-Analysis of Prognostic Factors, Clinical Epidemiology, vol.4, pp.283-301, 2012. ,
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure, Journal of Clinical Oncology, vol.25, issue.29, pp.4575-80, 2007. ,
DOI : 10.1200/JCO.2007.11.0833
Surgical Treatment of Hepatic Colorectal Metastasis, The Cancer Journal, vol.16, issue.2, 2016. ,
DOI : 10.1097/PPO.0b013e3181d7e8e5
Quelles métastases hépatiques sont résécables d'emblée ?, Gastroenterol Clin Biol, vol.27, issue.suppl2, pp.41-62, 2003. ,
Is Extended Hepatectomy for Hepatobiliary Malignancy Justified?, Annals of Surgery, vol.239, issue.5, pp.722-754, 2004. ,
DOI : 10.1097/01.sla.0000124385.83887.d5
Surgical treatment of hepatic metastases from colorectal cancer In: Blumgart LH. Surgery of the liver, biliary tract, and pancreas, pp.1178-1194, 2007. ,
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases, Journal of Clinical Oncology, vol.24, issue.13, pp.2065-72, 2006. ,
DOI : 10.1200/JCO.2005.05.3074
Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy, Transactions of the ... Meeting of the American Surgical Association, vol.CXXII, issue.&NA;, pp.644-57, 2004. ,
DOI : 10.1097/01.sla.0000141198.92114.f6
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study, Journal of Clinical Oncology, vol.22, issue.2, pp.229-266, 2004. ,
DOI : 10.1200/JCO.2004.05.113
Meta-Analysis Group in Cancer: Reappraisal of Hepatic Arterial Infusion in the Treatment of Non Resectable Liver Metastases from Colorectal Cancer, p.7269, 1942. ,
Preoperative selective portal vein embolization before hepatectomy for liver metastases: Long-term results and impact on survival, Surgery, vol.131, issue.3, pp.294-99, 2002. ,
DOI : 10.1067/msy.2002.120234
Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases, Annals of Surgery, vol.247, issue.3, pp.451-55, 2008. ,
DOI : 10.1097/SLA.0b013e31815ed693
Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab, Annals of Surgical Oncology, vol.25, issue.6, pp.1553-59, 2009. ,
DOI : 10.1097/01.sla.0000145964.08365.01
Preoperative Portal Vein Embolization Tailored to Prepare the Liver for Complex Resections: Initial Experience, CardioVascular and Interventional Radiology, vol.176, issue.2, pp.976-82, 2010. ,
DOI : 10.2214/ajr.176.2.1760483
The Brisbane, Terminology of Liver Anatomy and Resections. HPB HPB: The Official Journal of the International Hepato Pancreato Biliary Association, vol.2, issue.4 2, pp.333-372, 1080. ,
Comparison Between Hepatic Wedge Resection and Anatomic Resection for Colorectal Liver Metastases, Journal of Gastrointestinal Surgery, vol.10, issue.1, pp.86-94, 2006. ,
DOI : 10.1016/j.gassur.2005.07.022
Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: Evaluation with postoperative follow-up results, World Journal of Surgery, vol.152, issue.4, pp.551-5610, 1991. ,
DOI : 10.1148/radiology.156.2.2989974
Resection of Synchronous Liver Metastases from Colorectal Cancer, Japanese Journal of Clinical Oncology, vol.30, issue.1, pp.7-11, 2000. ,
DOI : 10.1093/jjco/hyd002
Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases, Surgery, vol.136, issue.3, pp.650-59, 2004. ,
DOI : 10.1016/j.surg.2004.02.012
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis, Journal of the American College of Surgeons, vol.197, issue.2, pp.233-274, 2003. ,
DOI : 10.1016/S1072-7515(03)00390-9
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.230, issue.3, pp.309-327, 1999. ,
DOI : 10.1097/00000658-199909000-00004
Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases, Annals of Surgical Oncology, vol.66, issue.4, pp.347-53, 2001. ,
DOI : 10.1007/s10434-001-0347-3
Liver Resection for Multiple Colorectal Metastases, Archives of Surgery, vol.137, issue.10, pp.1187-1192, 2002. ,
DOI : 10.1001/archsurg.137.10.1187
Bilobar Colorectal Liver Metastases: Treatment Options, Surgical Oncology Clinics of North America, vol.17, issue.3, pp.553-68, 2008. ,
DOI : 10.1016/j.soc.2008.02.006
Management of hepatic metastasis from colorectal cancers: an update, Journal of Hepato-Biliary-Pancreatic Surgery, vol.140, issue.6, pp.570-80, 2008. ,
DOI : 10.1067/msy.2001.112486
Patterns of Failure Following Surgical Resection of Colorectal Cancer Liver Metastases: Rationale for a Multimodal Approach, Annals of Surgery, vol.205, issue.3, pp.264-70, 1987. ,
DOI : 10.1007/978-3-642-83293-2_24
Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?, Journal of Clinical Oncology, vol.24, issue.24, pp.3939-3984, 2006. ,
DOI : 10.1200/JCO.2006.05.8727
Repeat hepatectomy for recurrent colorectal liver metastases, Journal of Surgical Oncology, vol.89, issue.1, pp.1-7, 2006. ,
DOI : 10.1002/jso.20384
Liver Resection for Colorectal Metastases, Annals of Surgery, vol.238, issue.6, pp.871-83, 2003. ,
DOI : 10.1097/01.sla.0000098112.04758.4e
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement, Annals of Surgical Oncology, vol.12, issue.10, pp.1271-80, 2006. ,
DOI : 10.1007/BF02725339
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases, Annals of Surgery, vol.235, issue.6, pp.759-66, 2002. ,
DOI : 10.1097/00000658-200206000-00002
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer, New England Journal of Medicine, vol.351, issue.4, pp.337-382, 2004. ,
DOI : 10.1056/NEJMoa033025
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.343, issue.13, pp.905-1410, 2000. ,
DOI : 10.1056/NEJM200009283431302
Patient Selection for Hepatic Resection for Metastatic Colorectal Cancer, Journal of Gastrointestinal Oncology, vol.3, issue.1, 2012. ,
A Retrospective Study of the Natural History of Patients with Liver Metastases from Colorectal Cancer, Clinical Oncology, vol.2, issue.3, pp.285-88, 1976. ,
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584., Journal of Clinical Oncology, vol.9, issue.7, pp.1105-1117, 1991. ,
DOI : 10.1200/JCO.1991.9.7.1105
Resection of Hepatic Metastases From Colorectal Cancer, Archives of Surgery, vol.119, issue.6, pp.647-51, 1960. ,
DOI : 10.1001/archsurg.1984.01390180015003
Radiofrequency ablation permits an effective treatment for colorectal liver metastasis, European Journal of Surgical Oncology (EJSO), vol.33, issue.1, pp.67-71, 2007. ,
DOI : 10.1016/j.ejso.2006.10.040
Radio-frequency ablation of colorectal liver metastases in 167 patients, European Radiology, vol.15, issue.5, pp.2261-67, 2004. ,
DOI : 10.1148/radiology.196.1.7540310
Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention, The British Journal of Radiology, vol.26, issue.1002, pp.556-65, 2011. ,
DOI : 10.1093/annonc/mdl029
Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 Patients, Annals of Surgery, vol.239, issue.4, pp.450-58, 2004. ,
DOI : 10.1097/01.sla.0000118373.31781.f2
Complications of radiofrequency coagulation of liver tumours, British Journal of Surgery, vol.217, issue.10, pp.1206-1228, 2002. ,
DOI : 10.1046/j.1365-2168.2002.02168.x
Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices, Journal of Vascular and Interventional Radiology, vol.21, issue.8, pp.192-203, 2010. ,
DOI : 10.1016/j.jvir.2010.04.007
Microwave Ablation for Hepatic Malignancies, Annals of Surgery, vol.259, issue.6, pp.1195-1200, 2014. ,
DOI : 10.1097/SLA.0000000000000234
Complications after Percutaneous Ablation of Liver Tumors: A Systematic Review, Hepatobiliary Surgery and Nutrition, vol.3, issue.5, pp.317-340, 2014. ,
Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series, Abdominal Radiology, vol.20, issue.176???181, pp.767-80, 2016. ,
DOI : 10.1016/j.rpor.2014.10.002
Percutaneous Ablation of Peribiliary Tumors with Irreversible Electroporation, Journal of Vascular and Interventional Radiology, vol.25, issue.1, pp.112-130, 2014. ,
DOI : 10.1016/j.jvir.2013.10.012
A Clinical-Pharmacological Evaluation of Hepatic Arterial Infusions of 5-Fluoro-2?-Deoxyuridine and 5-Fluorouracil, Cancer Research, vol.38, issue.11 1, pp.3784-92, 1978. ,
Fluoropyrimidine-HAI (hepatic Arterial Infusion) versus Systemic Chemotherapy (SCT) for Unresectable Liver Metastases from Colorectal Cancer, The Cochrane Database of Systematic Reviews, issue.3, 2009. ,
Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases, Annals of Surgery, vol.251, issue.4, pp.686-91, 2010. ,
DOI : 10.1097/SLA.0b013e3181d35983
Interventional revisions of malfunctions affecting surgically implanted port-catheters for hepatic artery infusion, Surgical Oncology, vol.22, issue.1, pp.48-54, 2013. ,
DOI : 10.1016/j.suronc.2012.10.002
Percutaneous Femoral Implantation of an Arterial Port Catheter for Intraarterial Chemotherapy: Feasibility and Predictive Factors of Long-term Functionality, Journal of Vascular and Interventional Radiology, vol.21, issue.11, pp.1681-88, 2010. ,
DOI : 10.1016/j.jvir.2010.08.003
Intra-Arterial Hepatic Chemotherapy: A Comparison of Percutaneous Versus Surgical Implantation of Port-Catheters, CardioVascular and Interventional Radiology, vol.27, issue.4, pp.973-79, 2011. ,
DOI : 10.1097/01.COC.0000071465.29907.A5
Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease, Annals of Surgical Oncology, vol.21, issue.3, pp.815-836, 2014. ,
DOI : 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R
Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure, Annals of Surgical Oncology, vol.49, issue.1, pp.219-245, 2008. ,
DOI : 10.1245/s10434-007-9581-7
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial., Journal of Clinical Oncology, vol.10, issue.7, pp.1112-1130, 1992. ,
DOI : 10.1200/JCO.1992.10.7.1112
Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the F??d??ration Nationale des Centres de Lutte Contre le Cancer, Journal of Clinical Oncology, vol.23, issue.22, pp.4881-87, 2005. ,
DOI : 10.1200/JCO.2005.05.120
Chemoembolization and Radioembolization for Hepatocellular Carcinoma Clinical Gastroenterology and Hepatology : The Official Clinical Practice, Journal of the American Gastroenterological Association, vol.11, issue.6, pp.604-648, 2013. ,
Determinants of Postembolization Syndrome after Hepatic Chemoembolization, Journal of Vascular and Interventional Radiology, vol.12, issue.3, pp.321-347, 2001. ,
DOI : 10.1016/S1051-0443(07)61911-3
Interventional Radiology: A Survival Guide Accessed, 2016. ,
Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations, HPB, vol.17, issue.1, pp.52-65, 2015. ,
DOI : 10.1111/hpb.12273
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases, World Journal of Gastroenterology, vol.22, issue.11, pp.3127-3176, 2016. ,
DOI : 10.1186/1471-2407-14-497
Arterial Patency after Repeated Hepatic Artery Bland Particle Embolization, Journal of Vascular and Interventional Radiology, vol.21, issue.4, pp.522-548, 2010. ,
DOI : 10.1016/j.jvir.2009.12.390
Repeated Bland-TAE Using Small Microspheres Injected via an Implantable Port???Catheter System for Liver Metastases: An Initial Experience, CardioVascular and Interventional Radiology, vol.56, issue.2, pp.493-97, 2014. ,
DOI : 10.1016/j.jhep.2011.09.012
Superselective Particle Embolization Enhances Efficacy of Radiofrequency Ablation: Effects of Particle Size and Sequence of Action, CardioVascular and Interventional Radiology, vol.17, issue.3, pp.773-82, 2013. ,
DOI : 10.1097/01.RVI.0000228416.21560.7F
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma, Hepatology, vol.12, issue.5, pp.1164-71, 2002. ,
DOI : 10.1053/jhep.2002.33156
In Vivo and in Vitro Analysis of the Effectiveness of Doxorubicin Combined with Temporary Arterial Occlusion in Liver Tumors, Journal of Vascular and Interventional Radiology, vol.4, issue.6, pp.741-788, 1993. ,
DOI : 10.1016/S1051-0443(93)71965-X
Colorectal metastases to the liver: selective chemoembolization., Radiology, vol.189, issue.2, pp.417-439, 1993. ,
DOI : 10.1148/radiology.189.2.8210369
Salvage Therapy for Liver-dominant Colorectal Metastatic Adenocarcinoma: Comparison between Transcatheter Arterial Chemoembolization versus Yttrium-90 Radioembolization, Journal of Vascular and Interventional Radiology, vol.20, issue.3, pp.360-67, 2009. ,
DOI : 10.1016/j.jvir.2008.11.019
Repeated Transarterial Chemoembolization in the Treatment of Liver Metastases of Colorectal Cancer: Prospective Study, Radiology, vol.250, issue.1, pp.281-89, 2009. ,
DOI : 10.1148/radiol.2501080295
Chemoembolization of Colorectal Liver Metastases with Cisplatin, Doxorubicin, Mitomycin C, Ethiodol, and Polyvinyl Alcohol, Cancer, vol.117, issue.2, pp.343-52, 2011. ,
Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial, Journal of Gastrointestinal Surgery, vol.26, issue.8, pp.1531-1569, 2012. ,
DOI : 10.1200/jco.2008.26.15_suppl.14608
Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model, CardioVascular and Interventional Radiology, vol.12, issue.1, pp.1448-59, 2012. ,
DOI : 10.1111/j.1477-2574.2009.00117.x
DC Bead: In Vitro Characterization of a Drug-delivery Device for Transarterial Chemoembolization, Journal of Vascular and Interventional Radiology, vol.17, issue.2, pp.335-377, 2006. ,
DOI : 10.1097/01.RVI.0000195323.46152.B3
Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants, Journal of Hepatology, vol.55, issue.6, pp.1332-1370, 2011. ,
DOI : 10.1016/j.jhep.2011.03.024
Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update, European Radiology, vol.25, issue.2, pp.1025-1059, 2007. ,
DOI : 10.2214/ajr.172.3.10063851
Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies, Journal of Clinical Oncology, vol.25, issue.8, pp.978-86, 2007. ,
DOI : 10.1200/JCO.2006.09.8657
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry, Journal of Oncology, vol.215, issue.1, pp.539795-539805, 2009. ,
DOI : 10.1016/j.ejps.2006.09.002
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study, CardioVascular and Interventional Radiology, vol.20, issue.6, pp.1523-1554, 2015. ,
DOI : 10.1016/j.jvir.2008.11.019
Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.1, pp.13-23, 2007. ,
DOI : 10.1016/j.ijrobp.2006.11.060
Traitement intra-art??riel des m??tastases h??patiques de cancer colorectal, Journal de Radiologie, vol.92, issue.9, pp.835-876, 2011. ,
DOI : 10.1016/j.jradio.2011.07.008
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres, International Journal of Radiation Oncology*Biology*Physics, vol.40, issue.3, pp.583-92, 1998. ,
DOI : 10.1016/S0360-3016(97)00818-3
Chemoembolization and Radioembolization for Hepatocellular Carcinoma Clinical Gastroenterology and Hepatology : The Official Clinical Practice, Journal of the American Gastroenterological Association, vol.11, issue.6, pp.604-648, 2013. ,
Radiation Dose Limits and Liver Toxicities Resulting from Multiple Yttrium-90 Radioembolization Treatments for Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, vol.18, issue.11, pp.1375-82, 2007. ,
DOI : 10.1016/j.jvir.2007.07.016
Treatment of Nonresectable Hepatocellular Carcinoma with Intrahepatic 90Y- Microspheres, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol.41, issue.10, pp.1673-81, 2000. ,
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer, BMC Cancer, vol.45, issue.2, pp.497-507, 2014. ,
DOI : 10.1016/j.ejca.2008.10.026
Randomised phase 2 trial of SIR-Spheres?? plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer, Journal of Surgical Oncology, vol.7, issue.Supp 2, pp.78-85, 2004. ,
DOI : 10.1023/A:1008200825886
Yttrium-90 Radioembolization of Malignant Tumors of the Liver: Gallbladder Effects, American Journal of Roentgenology, vol.202, issue.5, pp.1130-1165, 2014. ,
DOI : 10.2214/AJR.13.10548
Biliary Sequelae following Radioembolization with Yttrium-90 Microspheres, Journal of Vascular and Interventional Radiology, vol.19, issue.5 ,
DOI : 10.1016/j.jvir.2008.01.003
Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study, European Journal of Cancer, vol.49, issue.15, pp.3122-3152, 1990. ,
DOI : 10.1016/j.ejca.2013.05.012
Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy, Clinical Colorectal Cancer, vol.13, issue.1, pp.27-36, 2014. ,
DOI : 10.1016/j.clcc.2013.11.010
Randomised trial of SIR-Spheres?? plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer, Annals of Oncology, vol.12, issue.12, pp.1711-1731, 2001. ,
DOI : 10.1023/A:1013569329846
Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy, Journal of Clinical Oncology, vol.28, issue.23, pp.3687-94, 2010. ,
DOI : 10.1200/JCO.2010.28.5643
Radioembolization-Induced Liver Disease, Liver Radioembolization with 90Y Microspheres, pp.177-85, 1007. ,
DOI : 10.1007/174_2013_817
Long-Term Results of Single Course of Adjuvant Intraportal Chemotherapy for Colorectal Cancer, The Lancet, vol.345, issue.8946, pp.349-53, 1995. ,
EBSCOhost | 35276937 | Adjuvant Perioperative Portal Vein or Peripheral Intravenous Chemotherapy for Potentially Curative Colorectal Cancer: Long-Term Results of a Randomized Controlled Trial, International Journal of Colorectal Disease, 2016. ,
A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer, Molecular Therapy, vol.17, issue.2, pp.389-94, 2009. ,
DOI : 10.1038/mt.2008.240
The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 Is the New Standard for Oncology Clinical Trials, ASCO Meeting Abstracts, vol.22, issue.14_suppl, p.6098, 2004. ,
The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study, European Journal of Surgical Oncology (EJSO), vol.30, issue.8, pp.834-875, 2004. ,
DOI : 10.1016/j.ejso.2004.06.010
Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases, Annals of Surgical Oncology, vol.90, issue.1, pp.35-41, 2009. ,
DOI : 10.1002/bjs.4160
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases, Annals of Surgery, vol.239, issue.6, pp.818-843, 2004. ,
DOI : 10.1097/01.sla.0000128305.90650.71
The Impact of Adding Low-Dose Leucovorin to Monthly 5-Fluorouracil in Advanced Colorectal Carcinoma: Results of a Phase III Trial, Annals of Oncology, vol.9, issue.5, pp.535-576, 1998. ,
DOI : 10.1023/A:1008270916325
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.22, issue.1, pp.23-30, 2004. ,
DOI : 10.1200/JCO.2004.09.046
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.360, issue.14, pp.1408-1710, 2009. ,
DOI : 10.1056/NEJMoa0805019
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver, The Oncologist, vol.14, issue.11, pp.1095-1105, 2009. ,
DOI : 10.1634/theoncologist.2009-0152
Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases, World Journal of Surgery, vol.5, issue.9, pp.684-92, 2011. ,
DOI : 10.1097/00000421-198212000-00014
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads, Journal of Hepatology, vol.56, issue.3, pp.609-626, 2012. ,
DOI : 10.1016/j.jhep.2011.09.012